Protocolo de manejo multimodal del cáncer de pulmón: cirugía, radioterapia y tratamiento sistémico. Indicaciones terapéuticas y paliativas de la cirugía y la radioterapia
J. Chamorro, J.C. Calvo, M. García-Pardo, G. González, S. Roa, Y. Lage, A. Barril, M.E. Olmedo, V. Alía, P. Garrido
{"title":"Protocolo de manejo multimodal del cáncer de pulmón: cirugía, radioterapia y tratamiento sistémico. Indicaciones terapéuticas y paliativas de la cirugía y la radioterapia","authors":"J. Chamorro, J.C. Calvo, M. García-Pardo, G. González, S. Roa, Y. Lage, A. Barril, M.E. Olmedo, V. Alía, P. Garrido","doi":"10.1016/j.med.2025.03.008","DOIUrl":null,"url":null,"abstract":"<div><div>Lung cancer requires accurate staging for the best therapeutic approach. Surgery, radiotherapy, and systemic therapies are the mainstays of treatment. The first two are more relevant in early and potentially curative stages. Given the complexity of the cases and the multimodality of the treatments, joint decision making by a multidisciplinary tumor committee is essential in order to choose the best alternative.</div></div>","PeriodicalId":100912,"journal":{"name":"Medicine - Programa de Formación Médica Continuada Acreditado","volume":"14 27","pages":"Pages 1622-1626"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine - Programa de Formación Médica Continuada Acreditado","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304541225000526","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Lung cancer requires accurate staging for the best therapeutic approach. Surgery, radiotherapy, and systemic therapies are the mainstays of treatment. The first two are more relevant in early and potentially curative stages. Given the complexity of the cases and the multimodality of the treatments, joint decision making by a multidisciplinary tumor committee is essential in order to choose the best alternative.